We are live on ! Find out more
MTIP

Magee Thomson Investment Partners Portfolio holdings

AUM $259M
1-Year Est. Return 34.48%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+34.48%
3 Year Est. Return
+94.32%
5 Year Est. Return
10 Year Est. Return
AUM
$402M
AUM Growth
-$3.67M
Cap. Flow
-$18.5M
Cap. Flow %
-4.61%
Top 10 Hldgs %
43.26%
Holding
186
New
41
Increased
31
Reduced
36
Closed
31

Sector Composition

Rank Sector Weight
1 Healthcare 30.25%
2 Technology 27.86%
3 Communication Services 12.84%
4 Consumer Discretionary 12.29%
5 Industrials 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZEN
76
DELISTED
ZENDESK INC
ZEN
$151K 0.04%
+6,149
New +$145K
MKTO
77
DELISTED
MARKETO INC COM STK (DE)
MKTO
$151K 0.04%
4,597
SRCI
78
DELISTED
SRC Energy Inc
SRCI
$149K 0.04%
11,795
EFII
79
DELISTED
Electronics for Imaging
EFII
$148K 0.04%
3,427
IBP icon
80
Installed Building Products
IBP
$6.52B
$146K 0.04%
+8,165
New +$131K
ARQ icon
81
Arq
ARQ
$90.6M
$146K 0.04%
6,351
-239
-4% -$4.9K
CEMP
82
DELISTED
Cempra, Inc.
CEMP
$143K 0.04%
+6,052
New +$90.4K
EXP icon
83
Eagle Materials
EXP
$6.48B
$135K 0.03%
1,764
-2,168
-55% -$183K
NSTG
84
DELISTED
NanoString Technologies, Inc.
NSTG
$113K 0.03%
8,167
VNCE icon
85
Vince Holding Corp
VNCE
$88.1M
$112K 0.03%
+434
New +$138K
CKEC
86
DELISTED
Carmike Cinemas Inc
CKEC
$108K 0.03%
4,133
CSIQ icon
87
Canadian Solar
CSIQ
$1.05B
$102K 0.03%
4,244
KERX
88
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$99K 0.02%
7,057
MACK
89
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$99K 0.02%
+1,128
New +$82.2K
SLCA
90
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$85K 0.02%
3,327
-2,116
-39% -$83.6K
ACGN
91
DELISTED
Aceragen Inc
ACGN
$64K 0.02%
107
GWPH
92
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$55K 0.01%
826
CTIC
93
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$50K 0.01%
2,148
XOMA
94
DELISTED
Xoma
XOMA
$48K 0.01%
662
CLDX icon
95
Celldex Therapeutics
CLDX
$3.26B
$39K 0.01%
143
TSEM icon
96
Tower Semiconductor
TSEM
$25.4B
$9K ﹤0.01%
700
-72
-9% -$808
TA
97
DELISTED
TravelCenters of America LLC
TA
$9K ﹤0.01%
136
+34
+33% +$1.67K
RESN
98
DELISTED
Resonant Inc.
RESN
$9K ﹤0.01%
+812
New +$6.04K
PFPT
99
DELISTED
Proofpoint, Inc.
PFPT
$9K ﹤0.01%
174
+22
+14% +$942
TTPH
100
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$9K ﹤0.01%
10
-15
-60% -$8.07K

Similar funds

Magee Thomson Investment Partners's Q4 2014 Portfolio in Review

As of Q4 2014, Magee Thomson Investment Partners held 186 positions worth $402M, down 0.9% from $406M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Magee Thomson Investment Partners withdrew a net $18.5M in Q4 2014, closing 31 positions and reducing 36 holdings. Its most notable exit was B/E Aerospace Inc, an estimated $11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 27% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Magee Thomson Investment Partners opened a new position in Celgene Corp worth $11.6M.

  • Magee Thomson Investment Partners's largest Q4 2014 buy was Celgene Corp: 103,550 shares worth $11.6M.
  • Magee Thomson Investment Partners added most to Mastercard in Q4 2014, an estimated $3.57M increase.
  • Magee Thomson Investment Partners's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $7.52M.
  • Magee Thomson Investment Partners fully exited B/E Aerospace Inc in Q4 2014, selling an estimated $11M.
  • Magee Thomson Investment Partners's ten largest holdings make up 43% of its $402M portfolio in Q4 2014.
  • Magee Thomson Investment Partners opened 41 new positions and closed 31 in Q4 2014.
  • Magee Thomson Investment Partners's portfolio value fell 0.9% quarter-over-quarter to $402M.

Based on Magee Thomson Investment Partners's 13F filing for Q4 2014, filed 15 Jan 2015.